CRDF
Cardiff Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.09
+0.93%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.33x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.22x
Liquidity & coverage
- Current ratio
- 3.30x
- Quick ratio
- 3.30x
- Cash ratio
- 3.20x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $24.8M
Cash & dividend
- FCF / debt
- -89.53x
- Cash flow / debt
- -89.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026